Management of prolactinomas during pregnancy

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 44, Issue 12 SUPPL., 1999, Pages 1121-1126

  Molitch, Mark E ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Bromocriptine; Cabergoline; Hyperprolactinemia; Prolactinoma

Indexed keywords

BROMOCRIPTINE; CABERGOLINE; DOPAMINE RECEPTOR STIMULATING AGENT; PROLACTIN;

ANOVULATION; ARTICLE; DRUG SAFETY; FEMALE; FEMALE INFERTILITY; FETUS OUTCOME; FOLLOW UP; HUMAN; HYPERPROLACTINEMIA; HYPOPHYSIS ADENOMA; PREGNANCY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROLACTINOMA; VISUAL FIELD;

ADULT; DOPAMINE AGONISTS; FEMALE; HUMANS; HYPERPROLACTINEMIA; INFERTILITY, FEMALE; PITUITARY NEOPLASMS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PROLACTINOMA;

EID: 0033403616     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Krupp P, Monka C: Bromocriptine in pregnancy: Safety aspects. Klin Wochenschr 1987;65:823-827
2. Krupp P, Monka C, Richter K: The safety aspects of infertility treatments. Proc of the Second World Congress of Gynecology and Obstetrics, Rio de Janeiro, October 1988
3. Raymond JP, Goldstein E, Konopka P, et al: Follow-up of children born of bromocriptine-treated mothers. Hormone Res 1985;22:239-246
4. Konopka P, Raymond JP, Merceron RE, et al: Continuous administration of bromocriptine in the prevention of neurological complications in pregnant women with prolactinomas. Am J Obstet Gynecol 1983;146:935-938
5. Canales ES, García IC, Ruíz JE, et al: Bromocriptine as prophylactic therapy in prolactinoma during pregnancy. Fertil Steril 1981;36:524-526
6. Ruiz-Velasco V, Tolis G: Pregnancy in hyperprolactinemic women. Fertil Steril 1984;41:793-805
7. Ylikorkala O, Kivinen S, Rönnberg L: Bromocriptine treatment during early human pregnancy: Effect on the levels of prolactin, sex steroids and placenta lactogen. Acta Endocrinol 1980;95:412-441
8. Lehmann WD, Musch K, Wolf AS: Influence of bromocriptine on plasma levels of prolactin and steroid hormones in the 20th week of pregnancy. J Endocrinol Invest 1979;2: 251-255
9. Bigazzi M, Ronga R, Lancrangan I, et al: A pregnancy in an acromegalic woman during bromocriptine treatment: Effects on growth hormone and prolactin in the maternal, fetal, and amniotic compartments. J Clin Endocrinol Metab 1979;48: 9-12
10. Robert E, Musatti L, Piscitelli G, et al: Pregnancy outcome after treatment with the ergot derivative, cabergoline. Reprod Toxicol 1996;10:333-337
11. Pharmacia & Upjohn, Inc: Data on file, June 1999
12. Vician L, Shupnik MA, Gorski J: Effects of estrogen on primary ovine pituitary cell cultures: Stimulation of prolactin secretion, synthesis, and preprolactin messenger ribonucleic acid activity. Endocrinology 1979;104:736-743
13. Maurer RA: Relationship between estradiol, ergocryptine, and thyroid hormone: Effects on prolactin synthesis and prolactin messenger ribonucleic acid levels. Endocrinology 1982;110:1515-1520
14. Rakoff JS, Yen SSC: Progesterone induced acute release of prolactin in estrogen primed ovariectomized women. J Clin Endocrinol Metab 1978;47:918-992
15. Rigg LA, Lein A, Yen SSC: Pattern of increase in circulating prolactin levels during human gestation. Am J Obstet Gynecol 1977;129:454-456
16. Goluboff LG, Ezrin C: Effect of pregnancy on the somatotroph and the prolactin cell of the human adenohypophysis. J Clin Endocrinol Metab 1969;29:1533-1538
17. Elster AD, Sanders TG, Vines FS, et al: Size and shape of the pituitary gland during pregnancy and post partum: Measurement with MR imaging. Radiology 1991;181:531-535
18. Miki Y, Asato R, Okumura R, et al: Anterior pituitary gland in pregnancy: Hyperintensity at MR. Radiology 1993;187: 229-223
19. Dinç H, Esen F, Demirci A, et al: Pituitary dimensions and volume measurements in pregnancy and post partum. Acta Radiol 1998;39:64-69
20. Pichon MF, Bression D, Peillon F, et al: Estrogen receptors in human pituitary adenomas. J Clin Endocrinol Metab 1980; 51:897-902
21. Kajtar T, Tomkin GH: Emergency hypophysectomy in pregnancy after induction of ovulation. Br Med J 1971;4:88-90
22. Swyer GIM, Little V, Harries BJ: Visual disturbance in pregnancy after induction of ovulation. Br Med J 1971;4:90-91
23. Falconer MA, Stafford-Bell MA: Visual failure from pituitary and parasellar tumours occurring with favourable outcome in pregnant women. J Neurol Neurosurg Psychiatry 1975; 38:919-993
24. Lamberts SWJ, Seldenrath HJ, Kwa HG, et al: Transient bitemporal hemianopsia during pregnancy after treatment of galactorrhea-amenorrhea syndrome with bromocriptine. J Clin Endocrinol Metab 1977;44:180-184
25. Corbey RS, Crysberg JRM, Rolland R: Visual abnormalities in a pregnancy following bromocriptine medication. Obstet Gynecol 1977;50:69-71
26. Jewelewicz R, Zimmerman EA, Carmel PW: Conservative management of a pituitary tumor during pregnancy following induction of ovulation with gonadotropins. Fertil Steril 1977;28:35-40
27. Burry KA, Schiller HS, Mills R, et al: Acute visual loss during pregnancy after bromocriptine-induced ovulation. Obstet Gynecol 1978;52:19-22
28. Nelson PB, Robinson AG, Archer DF, et al: Symptomatic pituitary tumor enlargement after induced pregnancy. J Neurosurg 1978;49:283-287
29. Gemzell C, Wang CF: Outcome of pregnancy in women with pituitary adenoma. Fertil Steril 1979;31:363-372
30. Griffith RW, Turkalj I, Braun P: Pituitary tumours during pregnancy in mother treated with bromocriptine. Br J Clin Pharmacol 1979;7:393-396
31. Molitch ME: Pregnancy and the hyperprolactinemic woman. N Engl J Med 1985;312:1365-1370
32. Kupersmith MJ, Rosenberg C, Kleinberg D: Visual loss in pregnant women with pituitary adenomas. Ann Intern Med 1994;121:473-477
33. Rossi A-M, Vilska S, Heinonen PK: Outcome of pregnancies in women with treated or untreated hyperprolactinemia. Eur J Obstet Gynecol Reprod Biol 1995;63:143-146
34. Musolino N, Bronstein M: Prolactinomas and pregnancy: Use of dopamine agonists: Bromocriptine and cabergoline. Proc of the 6th International Pituitary Congress, Long Beach, California, 1999
35. Bergh T, Nillius SJ, Wide L: Clinical course and outcome of pregnancies in amenorrhoeic women with hyperprolactinaemia and pituitary tumours. Br Med J 1978;1:875-880
36. Van Roon E, van der Vijver JCM, Gerretsen G, et al: Rapid regression of a suprasellar extending prolactinoma after bromocriptine treatment during pregnancy. Fertil Steril 1981;36:173-177
37. Maeda T, Ushiroyama T, Okuda K, et al: Effective bromocriptine treatment of a pituitary macroadenoma during pregnancy. Obstet Gynecol 1983;61:117-121
38. Crosignani P, Ferrari C, Mattei AM: Visual field defects and reduced visual acuity during pregnancy in two patients with prolactinoma: Rapid regression of symptoms under bromocriptine: Case reports. Br J Obstet Gynaecol 1984;91: 821-823
39. Belchetz PE, Carty A, Clearkin LG, et al: Failure of prophylactic surgery to avert massive pituitary expansion in pregnancy. Clin Endocrinol 1986;25:325-330
40. Modena G, Portioli I: Delivery after bromocriptine therapy (left). Lancet 1977;2:558
41. Espersen T, Ditzel J: Pregnancy and delivery under bromocriptine therapy. Lancet 1977;2:985-986
42. Yuen BH: Bromocriptine, pituitary tumours, and pregnancy (lett). Lancet 1978;2:1314
43. Crosignani PG, Mattei AM, Scraduelli C, et al: Is pregnancy the best treatment for hyperprolactinaemia? Hum Reprod 1989;4:910-912
44. Samaan NA, Schultz PN, Leavens TA, et al: Pregnancy after treatment in patients with prolactinoma: Operation versus bromocriptine. Am J Obstet Gynecol 1986;155:1300-1305
45. Ikegami H, Aono T, Koizumi K, et al: Relationship between the methods of treatment for prolactinomas and the puerperal lactation. Fertil Steril 1987;47:867-869
46. Laws ER, Fode NC, Randall RV, et al: Pregnancy following transsphenoidal resection of prolactin-secreting pituitary tumors. J Neurosurg 1983;58:685-688
47. McGarrigle HHG, Sarris S, Little V, et al: Induction of ovulation with clomiphene and human chorionic gonadotrophin in women with hyperprolactinaemic amenorrhoea. Br J Obstet Gynaecol 1978;85:692-697
48. Radwanska E, McGarrigle HHG, Little V, et al: Induction of ovulation in women with hyperprolactinemic amenorrhea using clomiphene and human chorionic gonadotropin of bromocriptine. Fertil Steril 1979;32:187-192
49. Bergh T, Skarin G, Nillius SJ, et al: Pulsatile GnRH therapy: An alternative successful therapy for induction of ovulation in infertile normo-and hyperprolactinaemic amenorrhoeic women with pituitary tumours. Acta Endocrinol 1985;110: 440-444
50. Gindoff PR, Loucopoulos A, Jewelewicz R. Treatment of hyperprolactinemic amenorrhea with pulsatile gonadotropinreleasing hormone therapy. Fertil Steril 1986;46:1156-1158
51. Narita O, Kimura T, Suganuma N, et al: Relationship between maternal prolactin levels during pregnancy and lactation in women with pituitary adenoma. Acta Obstet Gynecol Jpn 1985;37:758-762
52. Divers WA Jr, Yen SSC: Prolactin-producing microadenomas in pregnancy. Obstet Gynecol 1983;61:425-429
53. Brodsky JB, Cohen EN, Brown BW Jr, et al: Surgery during pregnancy and fetal outcome. Am J Obstet Gynecol 1980;138: 1165-1167